Effect of nicotine and nicotine metabolites on angiotensin-converting enzyme in human endothelial cells

Endothelium: Journal of Endothelial Cell Research

Volumn 15, Issue 5-6, 2008, Pages 239-245

  Ljungberg, Liza U ^a   Persson, Karin ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Angiotensin converting enzyme; Atherosclerosis; Endothelial cells; Nicotine; Nicotine Metabolites; Tobacco

Indexed keywords

3' HYDROXYCOTININE; COTININE; COTININE N OXIDE; DIPEPTIDYL CARBOXYPEPTIDASE; NICOTINE; NICOTINE DERIVATIVE; NICOTINE N' OXIDE; NORCOTININE; UNCLASSIFIED DRUG; AMINE OXIDE; COTININE-N-OXIDE; DRUG DERIVATIVE; HYDROXYCOTININE; NICOTINE 1 N OXIDE; NICOTINE 1-N-OXIDE; NICOTINIC AGENT;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL STIMULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME POLYMORPHISM; HUMAN; HUMAN CELL; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; UMBILICAL VEIN; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYME ACTIVATION; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

NICOTIANA TABACUM;

ATHEROSCLEROSIS; CELLS, CULTURED; COTININE; CYCLIC N-OXIDES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; NICOTINE; NICOTINIC AGONISTS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SMOKING; UP-REGULATION;

EID: 60549099640     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320802487627     Document Type: Article

References (29)

1. Ambrose, J. A. and Barua, R. S. (2004) The pathophysiology of cigarette smoking and cardiovascular disease: An update. Journal of the American College of Cardiology, 43, pp. 1731-1737.
2. Benowitz, N. L. (1997) The role of nicotine in smoking-related cardiovascular disease. Preventive Medicine, 26, pp. 412-417.
3. Benowitz, N. L. and Jacob 3rd, P. (1997) Individual differences in nicotine kinetics and metabolism in humans. NIDA Research Monograph, 173, pp. 48-64.
4. Benowitz, N. L. and Jacob 3rd, P. (2001) Trans-3′-hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking. British Journal of Clinical Pharmacology, 51, pp. 53-59.
5. Benowitz, N. L., Jacob 3rd, P., Fong, I. and Gupta, S. (1994) Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. Journal of Pharmacology and Experimental Therapeutics, 268, pp. 296-303.
6. Burns, D. M. (2003) Epidemiology of smoking-induced cardiovascular disease. Progress in Cardiovascular Diseases, 46, pp. 11-29.
7. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Bard, J. M., Bara, L. Ricard, S. et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 359, pp. 641-644.
8. Cheon, K. T., Choi, K. H., Lee, H. B., Park, S. K., Rhee, Y. K. and Lee, Y. C. (2000) Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung, 178, pp. 351-360.
9. Dzau, V. J. (1993) Vascular renin-angiotensin system and vascular protection. Journal of Cardiovascular Pharmacology, 22, pp. S1-S9.
10. Haboubi, N. A., Bignell, A. H. and Haboubi, N. Y. (1986) Serum angiotensin converting enzyme activity in cigarette smokers. Clinica Chimica Acta; International Journal of Clinical Chemistry, 154, pp. 69-72.
11. Hergens, M. P., Alfredsson, L., Bolinder, G., Lambe, M., Pershagen, G. and Ye, W. (2007) Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. Journal of Internal Medicine, 262, pp. 351-359.
12. Jaffe, E. A., Nachman, R. L., Becker, C. G. and Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. The Journal of Clinical Investigation, 52, pp. 2745-2756.
13. Kilaru, S., Frangos, S. G., Chen, A. H., Gortler, D., Dhadwal, A. K., Araim, O. and Sumpio, B. E. (2001) Nicotine: A review of its role in atherosclerosis. Journal of the American College of Surgeons, 193, pp. 538-546.
14. Mizuno, K., Yaginuma, K., Hashimoto, S., Toki, T., Nakamura, I. and Fukuchi, S. (1982) Acute effect of cigarette smoking on serum angiotensin-converting enzyme activity in normal man. The Tohoku Journal of Experimental Medicine, 137, pp. 113-114.
15. Moyer, T. P., Charlson, J. R., Enger, R. J., Dale, L. C., Ebbert, J. O., Schroeder, D. R. and Hurt, R. D. (2002) Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clinical Chemistry, 48, pp. 1460-1471.
16. Neunteufl, T., Heher, S., Kostner, K., Mitulovic, G., Lehr, S., Khoschsorur, G., Schmid, R. W., Maurer, G. and Stefenelli, T. (2002) Contribution of nicotine to acute endothelial dysfunction in long-term smokers. Journal of the American College of Cardiology, 39, pp. 251-256.
17. Ninomiya, Y., Kioi, S. and Arakawa, M. (1987) Serum angiotensin converting enzyme activity in ex-smokers. Clinica Chimica Acta, 164, pp. 223-226.
18. Pittilo, R. M. (2000) Cigarette smoking, endothelial injury and cardiovascular disease. International Journal of Experimental Pathology, 81, pp. 219-230.
19. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. The Journal of Clinical Investigation, 86, pp. 1343-1346.
20. Rigat, B., Hubert, C., Corvol, P. and Soubrier, F. (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Research, 20, p. 1433.
21. Rohani, M. and Agewall, S. (2004) Oral snuff impairs endothelial function in healthy snuff users. Journal of Internal Medicine, 255, pp. 379-383.
22. Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., Suzuki, Y., Mezzano, S., Plaza, J. J. and Egido, J. (2001) Role of the renin-angiotensin system in vascular diseases: Expanding the field. Hypertension, 38, pp. 1382-1387.
23. Sugiyama, Y., Yotsumoto, H. and Takaku, F. (1986) Increase of serum angiotensin-converting enzyme level after exposure to cigarette smoke and nicotine infusion in dogs. Respiration, 49, pp. 292-295.
24. Tiret, L., Rigat, B., Visvikis, S., Breda, C., Corvol, P., Cambien, F. and Soubrier, F. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. American Journal Of Human Genetics, 51, pp. 197-205.
25. Wei, L., Alhenc-Gelas, F., Soubrier, F., Michaud, A., Corvol, P. and Clauser, E. (1991) Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. Journal of Biological Chemistry, 266, pp. 5540-5546.
26. Weir, M. R. and Dzau, V. J. (1999) The renin-angiotensin-aldosterone system: A specific target for hypertension management. American Journal of Hypertension, 12, pp. 205S-213S.
27. Yildiz, D. (2004) Nicotine, its metabolism and an overview of its biological effects. Toxicon, 43, pp. 619-632.
28. Zevin, S., Gourlay, S. G. and Benowitz, N. L. (1998) Clinical pharmacology of nicotine. Clinics in Dermatology, 16, pp. 557-564.
29. Zhang, S., Day, I. and Ye, S. (2001) Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis, 154, pp. 277-283.